Dear Sir/Madam, Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find attached certificate issued by RTA ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has submitted the quarterly confirmation certificate from its Registrar and Share Transfer Agent (RTA), Purva Sharegistry (India) Pvt. Ltd., for the quarter ended 31st December 2025, as required under SEBI Regulation 74(5). The certificate confirms that no share certificates were dematerialised during the period from 1st October 2025 to 31st December 2025 (all entries show NIL). This is a standard quarterly compliance filing confirming the RTA has processed any dematerialisation requests received during the quarter. The company's ISIN is INE730E01016 and it is listed on both BSE (Scrip Code: 512217) and MSEI (Symbol: PRISMMEDI).
No material impact on shareholders or stock price. This is a routine procedural compliance submission confirming that no shares were converted from physical to electronic form during the quarter, indicating no notable change in shareholding structure.